GMS syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2090OMIM:138770Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

GMS syndrome (Goltz-Gorlin syndrome, also referred to as Gorlin-Chaudhry-Moss syndrome) is an extremely rare congenital disorder characterized by a distinctive combination of craniofacial, ocular, dental, and skeletal abnormalities. The condition was first described by Gorlin, Chaudhry, and Moss, and is classified under Orphanet code 2090. Key clinical features include craniosynostosis (premature fusion of skull bones), midface hypoplasia (underdevelopment of the middle portion of the face), hypertrichosis (excessive hair growth), patent ductus arteriosus or other congenital heart defects, and eye abnormalities such as microphthalmia or coloboma. Dental anomalies including hypodontia and delayed eruption are also commonly reported. Affected individuals may present with short stature, hearing impairment (often conductive), and genital anomalies. The craniofacial features can lead to functional problems including upper airway obstruction and feeding difficulties in infancy. Intelligence is typically normal, though developmental delays have been reported in some cases. There is no specific curative treatment for Gorlin-Chaudhry-Moss syndrome. Management is multidisciplinary and symptomatic, involving craniofacial surgery for craniosynostosis, cardiac surgery if congenital heart defects are hemodynamically significant, ophthalmologic care, dental management, and audiologic monitoring. Genetic counseling is recommended for affected families. Due to the extreme rarity of this condition, the natural history and long-term prognosis remain incompletely characterized.

Also known as:

Clinical phenotype terms— hover any for plain English:

Rieger anomalyHP:0000558
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for GMS syndrome.

View clinical trials →

No actively recruiting trials found for GMS syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the GMS syndrome community →

No specialists are currently listed for GMS syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to GMS syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open GMS syndromeForum →

No community posts yet. Be the first to share your experience with GMS syndrome.

Start the conversation →

Latest news about GMS syndrome

No recent news articles for GMS syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about GMS syndrome

What is GMS syndrome?

GMS syndrome (Goltz-Gorlin syndrome, also referred to as Gorlin-Chaudhry-Moss syndrome) is an extremely rare congenital disorder characterized by a distinctive combination of craniofacial, ocular, dental, and skeletal abnormalities. The condition was first described by Gorlin, Chaudhry, and Moss, and is classified under Orphanet code 2090. Key clinical features include craniosynostosis (premature fusion of skull bones), midface hypoplasia (underdevelopment of the middle portion of the face), hypertrichosis (excessive hair growth), patent ductus arteriosus or other congenital heart defects, and

How is GMS syndrome inherited?

GMS syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does GMS syndrome typically begin?

Typical onset of GMS syndrome is neonatal. Age of onset can vary across affected individuals.